When you take oral vitamin B12 supplements, your digestive system limits how much your body can absorb particularly for patients with absorption issues, digestive conditions, or advancing age
Integration-ready workflows enable seamless linkage of acylcarnitine data with other lipid classessupporting systems-level insight into fatty acid oxidation, mitochondrial transport, and amino acid catabolism
The AbsoluteIDQ p180 kit has been validated according to the European Medicine Agency Guidelines on bioanalytical method validation
Toxicol Lett 8283(C):969974
Document the clinical rationale per patient in the chart itself: why this compound, why this patient, what you expect to monitor
As a general clinical principle: Retest HbA1c no sooner than three months after commencing B12 replacement therapy, and ideally once haematological recovery has been confirmed Confirm haematological recovery normalisation of MCV and haemoglobin before interpreting the repeat HbA1c as reliable Use interim glucose monitoring such as fasting plasma glucose, OGTT, or self-monitored blood glucose (SMBG) to assess glycaemic control during the treatment period